Browse All

Current Filters

CLEAR FILTER x

TITLE

Expanding the Role of PSMA PET Beyond Prostate Cancer: Applications in Primary and Metastatic Central Nervous System Tumors

Author:Ricaurte-Fajardo, Andres   Paez-Garcia, Salomon   Marulanda-Corzo, Valentina   Diaz, Andres   Sierra-Peña, Julian Alfonso   Ocampo-Navia, Maria Isabel   Coral Casas, Juliana   Cardoza-Ochoa, David   Huicochea-Castellanos, Sandra   Osborne, Joseph R.   

Session Name:P9: Neuro-oncology: CNS Metastases 2  

Topic:Neuro-oncology  

Program Number:P9.010  

Author Institution:Pontificia Universidad Javeriana, Colombia  Weill Cornell Medicine, NY  University of Texas Medical Branch at Galveston, TX  

Expanding the Spectrum of COXFA4-Related Disease: A Case of a Reclassified Pathogenic Variant

Author:Rana, Shehroz   Giammarco, Danielle   Fitch, Courtney   Tang, Connie   

Session Name:P8: Neuromuscular and Clinical Neurophysiology (EMG): Muscle Disorders  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P8.008  

Author Institution:Lehigh Valley Health Network, Allentown, PA  Lehigh Valley Health Network, Bethlehem, PA  Lehigh Valley Health Network, PA  

Expanding the Therapeutic Horizon in CAA-related Inflammation: A Case Series of Rituximab Treatment

Author:Bahani, Roxana   Moreno Gomez, Veronica   Shoskes, Aaron   Bornovski, Yarden   Lyden, Stephanie   

Session Name:P1: Cerebrovascular Disease and Interventional Neurology: Rare Clinical Case Presentations  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P1.003  

Author Institution:University of Utah Health, UT  

Expanding Therapeutic Impact: Inclusion of Caregivers in a Community-based Parkinson’s Disease Program

Author:Ingersoll, Sarah   Mendenhall, Kris   Hayashida, Kenneth   Castro, Louis   

Session Name:P1: Practice, Policy, and Ethics 1  

Topic:Practice, Policy, and Ethics  

Program Number:P1.012  

Author Institution:University of Southern California, Pasadena, CA  Parkinson's Foundation Research Advocate, CA  retired, CA  Castropt.com, CA  

exPDite-2: A Phase Three, Randomized, Sham-controlled, Double-blind Trial to Evaluate Bemdaneprocel, a Midbrain Dopaminergic Neuron Progenitor Cell Therapy for Parkinson’s Disease

Author:Abid, Nauman   Adera, Mathews   Louie-Gao, Melinda   Belfort, Gabriel   

Session Name:P8: Movement Disorders: Parkinson's Disease Emerging Therapeutics 2  

Topic:Movement Disorders  

Program Number:P8.008  

Author Institution:BlueRock Therapeutics, Cambridge, MA